HIGJX
Price
$21.04
Change
+$0.16 (+0.77%)
Updated
Sep 11 closing price
Net Assets
488.31M
RMEBX
Price
$63.87
Change
+$0.34 (+0.54%)
Updated
Sep 11 closing price
Net Assets
117.47B
Interact to see
Advertisement

HIGJX vs RMEBX

HIGJX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
HIGJX vs. RMEBX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIGJX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. HIGJX (488M). HIGJX pays higher dividends than RMEBX: HIGJX (1.21) vs RMEBX (0.99). HIGJX was incepted earlier than RMEBX: HIGJX (18 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than HIGJX (0.72). HIGJX is a more actively managed with annual turnover of: 47.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than HIGJX: RMEBX (250) vs HIGJX (10000). RMEBX annual gain was more profitable for investors over the last year : 4.65 vs. HIGJX (-6.04). RMEBX return over 5 years is better than : 34.68 vs. HIGJX (-11.86).
HIGJXRMEBXHIGJX / RMEBX
Total Expense Ratio0.721.0767%
Annual Report Gross Expense Ratio0.721.0767%
Fund Existence18 years12 years-
Gain YTD10.2878.448122%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets488M117B0%
Annual Yield % from dividends1.210.99122%
Returns for 1 year-6.044.65-130%
Returns for 3 years2.1334.886%
Returns for 5 years-11.8634.68-34%
Returns for 10 years31.1492.4534%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOYU4.700.16
+3.52%
DouYu International Holdings Limited
CCTG0.610.01
+2.23%
CCSC Technology International Holdings Limited
QTWO60.890.56
+0.93%
Q2 Holdings
GEHC63.93-0.31
-0.48%
GE HealthCare Technologies
ACRS5.32-0.18
-3.36%
Aclaris Therapeutics